Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05500963 · ClinicalTrials.gov registry record · NA

Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS

A NA study of Multiple Sclerosis, sponsored by University of Colorado, Boulder.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05500963 is a NA study of Multiple Sclerosis that is actively recruiting participants, run by University of Colorado, Boulder. The registered enrollment target is 60 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05500963, a NA study of Multiple Sclerosis, is actively recruiting participants, sponsored by University of Colorado, Boulder.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The objective of the randomized, sham-controlled trial will be to evaluate the effectiveness of treatment with transcutaneous electrical nerve stimulation (TENS) at reducing the level of fatigue experienced by people with MS.

Conditions Studied

Interventions

  • DEVICE Transcutaneous electrical nerve stimulation

Study Locations (1)

Colorado

  • University of Colorado - Boulder

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-04-25
Est. Completion 2028-11-30
Phase NA

Sponsor

University of Colorado, Boulder

69 total trials

What the Registry Record Tells You About NCT05500963

The ClinicalTrials.gov registry entry for NCT05500963 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (90% lower). The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous electrical nerve stimulation is the first listed.

NCT05500963 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05500963 about?

NCT05500963 is a clinical study titled "Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS". The objective of the randomized, sham-controlled trial will be to evaluate the effectiveness of treatment with transcutaneous electrical nerve stimulation (TENS) at reducing the level of fatigue experienced by people with MS.

What is the current status of trial NCT05500963?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-04-25. Estimated completion is 2028-11-30.

What conditions does trial NCT05500963 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT05500963?

The interventions under investigation include: Transcutaneous electrical nerve stimulation (DEVICE).

Who is sponsoring clinical trial NCT05500963?

This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05500963 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.